Clinical Trial Update: A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes [Phase 2]

View source ↗

Summary

A completed Phase 2 pilot trial evaluating the combination of all-trans retinoic acid and interferon-alpha2a for lymphoproliferative disorders in children with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Immunodeficiency Syndromes
• Lymphoproliferative Disorders

Drugs mentioned

• All-trans retinoic acid (tretinoin) (tretinoin)
• Interferon-alpha2a (interferon alfa-2a)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HIV Infections, Immunologic Deficiency Syndromes | Phase 2 | Status: COMPLETED